Leuven.Inc seminar 'Regenerative medicine: from translational research towards a new industry'
This seminar is a joint organization of Leuven.Inc and Leuven Medical Technology Center (L-MTC), powered by Flanders Smart Hub.
“Regenerative medicine is a complex, multidisciplinary field with specific challenges in each step of the chain from basic scientific research to sustainable commercialization of tissue engineered products and services. The seminar will emphasize the translational and collaborative aspects of academic and industrial research. Company presentations will illustrate some of the steps needed for successful development, clinical testing, regulatory approval and market introduction of regenerative solutions in the fields of musculoskeletal repair, stem cell technology and heart valve replacement.”
Practical aspects
Date: Monday November 28th, 2011
Location: Thermotechnisch Instituut, Kasteelpark Arenberg 41, 3001 Leuven (Heverlee)
Programme
| 13h30: | Registration and coffee |
| 14h00: | Introduction and the K.U.Leuven approach (Prometheus platform) Jan Schrooten - Research Manager Biomaterials & Tissue Engineering K.U.Leuven |
| 14h30: | ITERA Life Science - Forum for Tissue Engineering & Regenerative Medicine Prof. dr. Albert Ramon - Chairmain Itera Life Sciences Forum |
| 15h00: | The role of biomaterials in regenerative medicine Dr. Aylvin Dias - Principal Scientist DSM Biomedical |
| 15h30: | SCIL Clinical (Late translational and clinical research): Up to a clinical trial Prof. dr. Stefaan Van Gool - Kliniekhoofd UZL en buitengewoon hoogleraar aan de K.U.Leuven |
| 16h00: | Coffee break |
| 16h30: | Anethon - Making the body accept cardiovascular devices as its own tissue Els Vanheusden - MD & CEO Anethon |
| 16h50: | QTIS/e - Heart valve tissue engineering Martijn Cox - Founder QTIS/e (Quality Tissue Engineering) |
| 17h10: | ReGenesys - Towards commercial stem cells dr. Jef Pinxteren - Head of R&D ReGenesys |
| 17h30: | TiGenix - Combination products, regulatory challenges, business opportunities Gil Beyen - Managing Director & CBO TiGenix (Celerix) |
| 17h50: | Q&A |
| 18h15: | Drinks and networking |
The interventions will be held in English
Participation fee
| 60 euro (excl. VAT): researchers affiliated and billable to academic institutes 115 euro (excl. VAT): members of Leuven.Inc/FSH partners 155 euro (excl. VAT): all others | |
 | Participation in our activities at -50% discount via KMO-portefeuille |
Registration
Registrations before Tuesday November 22nd, 2011, preferably via the online registration form (use the 'Register' button) or by email to admin@leuveninc.com (including all contact and invoice details).
After registration you will receive a confirmation and route description. The registration fee is payable after receipt of invoice. Cancellation after subscription is not possible. However, replacement by a colleague is allowed.*
* As an (Associate) Company Member you can be replaced by a colleague. As an individual Member you can only be replaced by another Individual Member. When this is not possible, Leuven.Inc will charge an extra fee for the replacement by a non-member.
Subscribe to our newsletter
Stay tuned and get our news in your inbox: subscribe here.
Keep me informed
